Navigation Links
Rheumatoid Arthritis Patients are Moderately to Highly Satisfied with Their Current Drug Therapy, Rating Conventional DMARDs Highest on Ease of Use and Cost
Date:5/29/2013

EXTON, Penn., May 29, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that rheumatoid arthritis patients are moderately to highly satisfied with the drugs, biologic and non-biologic, they are currently taking for their condition. Most of the surveyed patients indicate they are unlikely to request a change in therapy in the next year, supporting the finding that they are satisfied with their current medication.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36805LOGO)

The PatientTrends® Rheumatoid Arthritis (US) 2013 report finds that conventional disease-modifying antirheumatic drugs (DMARDs) are rated highest on ease of use and cost due to their oral formulations and generic availability. However, despite the fact that Pfizer's Xeljanz is a new oral agent, rheumatoid arthritis patients express a low likelihood to ask their doctor to prescribe Xeljanz, post-exposure to Xeljanz's profile. The high patient drug satisfaction finding is contrary to rheumatologists' views of the currently available rheumatoid arthritis drug treatments where, in the TreatmentTrends® Rheumatoid Arthritis (US) 2012 report, close to 50 percent of surveyed rheumatologists rated rheumatoid arthritis as a disease with a high unmet need for new drug therapies.   

"Approximately half of the surveyed rheumatoid arthritis patients taking conventional DMARDs and/or biologics do not experience any side effects," said BioTrends Senior Data Analyst Jen Dolga . "Therefore, if their current drug is working and they are not experiencing side effects, the patients are not going to ask their doctors to change their medication."

About BioTrends Research Group
BioTrends Research Grou
'/>"/>

SOURCE BioTrends Research Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
2. Patent Issued In U.S. For EntreMeds 2ME2 In Rheumatoid Diseases
3. AstraZeneca Announces Top-Line Results From OSKIRA-1 Phase 3 Study of Fostamatinib in Rheumatoid Arthritis
4. Specialty drug costs account for more than 50 percent of the total cost of care for rheumatoid arthritis and hepatitis C patients
5. Though Over One-Third of Rheumatologists Have Prescribed Xeljanz for Their Rheumatoid Arthritis Patients, Physicians are Still Concerned With the Drugs Limited Post-Marketing Experience and Risks of Infection and Malignancy
6. Lilly Discontinues Phase 3 Rheumatoid Arthritis Program for Tabalumab Based on Efficacy Results
7. Lilly Discontinues One of Three Phase 3 Rheumatoid Arthritis Registration Studies for Tabalumab
8. AstraZeneca Announces Top-Line Results of OSKIRA-4 Phase IIb Study of Fostamatinib as a Monotherapy for Rheumatoid Arthritis
9. UCB, Inc. and Arthritis Foundation Partner to Celebrate the "Everyday Victories" of the Rheumatoid Arthritis Community
10. Epidemiology: Rheumatoid Arthritis in China - Rapid urbanization presents favorable market potential
11. Phase 3 Data Show Intravenous Golimumab Inhibited Radiographic Progression in Patients with Active Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 10, 2014   LabStyle Innovations Corp . ... announced the appointment of Professor Richard B. ... Board of Directors. Prof. Stone brings ... to LabStyle as an entrepreneur, venture capitalist public, ... governance expert. He currently serves on the board ...
(Date:7/10/2014)... , July 10, 2014 Decision Resources ... awareness of the U.S. Food and Drug Administration,s (FDA) ... phosphate binder Velphoro, which was approved by the FDA ... chronic kidney disease (CKD) patients on dialysis. ... TreatmentTrends: Nephrology (US) Q2 2014 : ...
(Date:1/15/2014)... , Jan. 15, 2014 /PRNewswire-iReach/ -- ChinaMarketResearchReports.com adds "China ... store . (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) ... and policy support, China,s orthopedic ... with total market size rising from 3.28 billion yuan ...
Breaking Medicine Technology:LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3
... As a leader in unified RIS/PACS, Avreo continues ... for preview at RSNA.  Version 7 represents an extensive ... , All new modern design with focus ... Cross-platform support, including Windows®, Mac OS® X, Apple® ...
... Radiological Society of North America (RSNA) Annual Meeting will ... to FUJIFILM Medical Systems U.S.A., Inc.,s PACS offering from ... ® PACS 4.0 includes improvements to image visualization ... and improve overall efficiency.  The latest ...
Cached Medicine Technology:Avreo Previews Version 7 RIS/PACS at RSNA 2Fujifilm Demonstrates the Latest Advancements of Synapse® PACS at RSNA 2Fujifilm Demonstrates the Latest Advancements of Synapse® PACS at RSNA 3
(Date:7/13/2014)... COPENHAGEN, July 13, 2014 A decreased ability ... cognitive impairment and Alzheimer,s disease, while examinations of ... a protein associated with Alzheimer,s, in the brain, ... reported today at the Alzheimer,s Association International Conference ... of the studies, the decreased ability to identify ...
(Date:7/13/2014)... ECS is being founded by ... of a special needs child, I have become keenly ... for contemporary special education resources and evidence-based instruction. Emerald ... and families in the Seattle metro area that are ... education. We welcome the opportunity to serve our community ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 Recently, iFitDress.com, ... and women’s special occasion outfits, has added a new ... website. Furthermore, the company has launched a promotion for ... discount. , iFitDress.com is now providing thousands of ... products sell well in Britain, America, France, Italy and ...
(Date:7/12/2014)... 12, 2014 The Passenger Information System ... 2013 to $20,341.36 million by 2019, at an expected ... 2019. , The public transport infrastructure in North America ... available in almost every corner of the region. The ... of public transport service providers are driving the North ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 ... & Peripheral Vascular Devices Market by ... Drug-Eluting), Catheter (IVUS, OCT), IVC Filter ... to 2018" analyzes and studies the ... in the U.S. and Canada. , ...
Breaking Medicine News(10 mins):Health News:Smell and eye tests show potential to detect Alzheimer's early 2Health News:Smell and eye tests show potential to detect Alzheimer's early 3Health News:Smell and eye tests show potential to detect Alzheimer's early 4Health News:Smell and eye tests show potential to detect Alzheimer's early 5Health News:Smell and eye tests show potential to detect Alzheimer's early 6Health News:Smell and eye tests show potential to detect Alzheimer's early 7Health News:New Private School, Emerald City School, Founded in Downtown Seattle Now Accepting 1st to 6th Grade Students Who Learn Differently 2Health News:New and Beautiful Evening Dresses Unveiled by iFitDress.com 2Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 2Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 3Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 5
... a diseased liver from a Hepatitis C (HCV) patient. Virus ... transplant, which can even go beyond pre-transplant levels, // according ... for the Study of Liver Diseases’ (AASLD) Liver Transplantation journal. ... ,As many as six liver transplant patients ...
... the reason for neural tube defects outbreak in the Rio ... study published in the on line journal Environmental Health Perspectives ... by fungal toxins might give rise to neural tube defects ... ,Talking about “Neural tube defects” these are embryonic ...
... the effect of parental conflict on learning and behavioral ... to the consequent sleep disorders in children. //Although it ... parents lead to behavior and learning problems in children, ... new study, published in the latest issue of Child ...
... drilled into us that drink to your heart’s content to ... Boston marathon runners proves otherwise. ,488 runners of the ... blood- and it was// found that more than one in ... drinks too much water during exercise and then sodium levels ...
... commissioned by the Food and Drug Administration has found that ... with the drug makers and apprised them of their concerns ... phase of human testing. ,The report by consulting ... that 53 percent of drug makers who met with the ...
... More women in the age group of 60-79 are suceptible to ... rates are very optimistic. The survival statistics for this type ... years an impovement of 16% in a 30 year period. ... , suggesting a 30% increase in incidences of cancer in ...
Cached Medicine News:Health News:Fungal toxins infected corn the reason for congenital defects 2Health News:Parental Conflict Can Lead to Sleep Disorders in Children 2
... a lightweight, portable console display module. It has ... channels for up to one or two fiber ... alarms for low and high limits for StO2 ... and requires minimal training., ,Sensors of different depths ...
CO 2 SMO-Capnograph/Pulse Oximeter...
... the next generation in pulse oximetry monitoring ... current family of "digital pulse oximeters, MARSpO ... breakthroughs in signal processing. This provides improved ... superior performance during challenging clinical conditions such ...
... The Nellcor N-20PA Handheld Pulse Oximeter ... dependability. The durable construction of the N-20PA ... extreme temperatures and conditions it has ... It is conveniently portable for spot check ...
Medicine Products: